Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin

R. Bavalia, I.M. Bistervels, W.G. Boersma, I. Quere, D. Brisot, N. Falvo, D. Stephan, F. Couturaud, S. Schellong, K. Montaclair, W. Ghanima, M. ten Wolde, M. Coppens, E. Ferrari, O. Sanchez, P. Carroll, S.R. Kahn, K. Meijer, S. Birocchi, M.J. KovacsA. Hugman, H. ten Cate, H. Wik, G. Pernod, M.A. Grosso, M.G. Shi, Y. Lin, B.A. Hutten, P. Verhamme, S. Middeldorp*, J. Beyer-Westendorf, P.M. Roy, M.A. Sevestre-Pietri, Hokusai Post-PE Study Investigator

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article numbere12566
Number of pages11
JournalResearch and practice in thrombosis and haemostasis
Volume5
Issue number5
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • edoxaban
  • pulmonary embolism
  • quality of life
  • warfarin
  • VALIDATION

Cite this